Investigating the Causality and Perceptions of Adverse Events Following Immunization (AEFI) and the awareness of the Novel mRNA COVID-19 Vaccine in Tallinn Upper Secondary Schools
Abstract
The COVID-19 pandemic launched a multi-billion dollar and highly time-sensitive global search for a vaccine, leading to the world's first mRNA vaccines, which employed a revolutionary method of inoculation. Although mRNA vaccines have proven to be highly effective against COVID-19, their impact on the human body is still being investigated and there have been instances of public distrust of the vaccine, leading to some people refusing to take it. This study investigates three aspects in Tallinn secondary school students: how well they understand the basics of mRNA vaccination technology, why those who refused vaccination did so, and their perception of adverse reactions to the vaccine they received. For the practical part of the research, a questionnaire was used, among students of the 10th and 12th grades of a total of 20 schools. The questionnaire consisted of 13 questions: 10 multiple-choice and three open-ended. Each of the multiple-choice questions also had an "Other" option, which allowed students to input their own answer. The questionnaire was bilingual, including both Estonian and Russian speakers. A total of 168 10th grade students participated in the questionnaire, representing 61.5% of the respondents, and 105 12th grade students, representing 38.5% of the respondents. The results showed that awareness of mRNA vaccines among students in Tallinn was low, and adverse reactions to vaccination consisted mainly of fatigue and muscle pain. Parental refusal was the main reason for not vaccinating, and information was mainly obtained from social media.
Downloads
Published
Data Availability Statement
This research paper is available to students and teachers of Tallinn Mustamäe School, where the authors come from. Later this year, the work will be presented at a national research paper competition, where it can be presented to the Estonian public.
Issue
Section
License
Copyright (c) 2025 Intersect: The Stanford Journal of Science, Technology, and Society

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).